{"title": "Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites", "doi": "10.1101/2020.03.06.977876", "citation_id": "2020.03.06.977876v2", "date": "2020-03-11", "laguage": "en", "journal_title": "bioRxiv", "first_page": "2020.03.06.977876", "abstract": "<p>The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the  beta-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.</p>", "twitter_description": "The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the 2.7 \u00c5 crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the \u03b2-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.", "full_text_html_url": "https://www.biorxiv.org/content/10.1101/2020.03.06.977876v2.full", "public_url": "https://www.biorxiv.org/content/10.1101/2020.03.06.977876v2", "abstract_html_url": "https://www.biorxiv.org/content/10.1101/2020.03.06.977876v2.abstract", "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/03/11/2020.03.06.977876.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory", "pisa": "biorxiv;2020.03.06.977876v2", "access_rights": "restricted", "authors": ["Sisi Kang", "Mei Yang", "Zhongsi Hong", "Liping Zhang", "Zhaoxia Huang", "Xiaoxue Chen", "Suhua He", "Ziliang Zhou", "Zhechong Zhou", "Qiuyue Chen", "Yan Yan", "Changsheng Zhang", "Hong Shan", "Shoudeng Chen"]}